AIM ImmunoTech Inc.·4

Sep 12, 5:15 PM ET

Equels Thomas K 4

4 · AIM ImmunoTech Inc. · Filed Sep 12, 2024

Insider Transaction Report

Form 4
Period: 2024-09-11
Equels Thomas K
CEO & President
Transactions
  • Award

    Common Stock

    2024-09-11$0.32/sh+312,500$100,0001,468,042 total

Documents

1 file
  • 4
    ownership.xmlPrimary